Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
Study NCT ID:
NCT06848920
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-02-27
First Post:
2025-01-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma
Sponsor:
Zhejiang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2024102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None